Parse Biosciences Upgrades Immune Profiling Kits with v4 Chemistry…

Event summary

Parse Biosciences launched next-generation Evercode™ TCR and Evercode™ BCR kits on June 10, 2026.
The updated kits feature v4 chemistry, improving workflow efficiency and data quality.
Evercode BCR v4 enhances sensitivity for paired CDR3 detection and full-length heavy/light chain recovery.
Evercode TCR v4 preserves sensitive alpha-beta CDR3 pairing for T cell receptor profiling.

The big picture

Parse Biosciences' upgrade to its immune profiling kits aligns with the growing demand for high-throughput, sensitive tools in immunology research. The v4 chemistry unification streamlines workflows, potentially lowering barriers to large-scale immune repertoire and transcriptomic studies. This move could strengthen Parse's position in the competitive single-cell sequencing market, particularly in applications ranging from autoimmunity to cancer immunotherapy.

What we're watching

Adoption Pace: How quickly researchers will integrate the v4 chemistry kits into their workflows.
Data Quality Impact: Whether the improved sensitivity and efficiency will accelerate immune response discoveries.
Market Differentiation: How Parse Biosciences' unified workflow will position it against competitors in single-cell sequencing.